Nautilus Subsidiary, Inc.

National Technology & Engineering Solutions of Sandia, LLC

Nautilus Biotechnology, Inc.

Torri Elise Rinker

Parag Mallick

Stephen P Hendricks

Tural Aksel

Elvis Ikwa

Pierre F Indermuhle

Sadie Ingle

Steven Tan

Christina Inman

Dmitriy Gremyachinskiy

Michael Dorwart

Rachel Galimidi

Sonal Tonapi

Joshua Simon Klein

Markus Burns

Julia Robinson

Cassandra Stawicki

Pengyu Hao

C Jeffrey Brinker

David Stern

Christina E Inman

Ezra Van Gelder

Oscar Negrete

Vadim Lobanov

Ryan Kempston Seghers

Daniel Horner

Annette Estelle LaBauve

Maryam Jouzi

Kevin Chen

Compositions, systems, and methods for the display of analytes such as biomolecules are described. Display of analytes is achieved by coupling of the analytes to displaying molecules that are configured to associate with surfaces or interfaces. Arrays of analytes may be formed from the described systems for utilization in assays and other methods.

Systems and methods for biomolecule retention

Compositions, systems, and methods are disclosed for preparing and utilizing arrays, such as single-analyte arrays containing a plurality of fiducial elements with random spatial distributions. Arrays may be prepared with pluralities of fiducial elements comprising optically active or passive moieties. Arrays containing random spatial distributions of fiducial elements may be utilized for various array-based processes that require spatial information.

Integrated arrays for single-analyte processes

An affinity reagent, having: (a) a retaining component such as a structured nucleic acid particle; and (b) one or both of (i) one or more label components attached to the retaining component, and (ii) one or more binding components attached to the retaining component.

Affinity reagents having enhanced binding and detection characteristics

The present invention relates to lipid-coated particles for treating viral infections, including viral encephalitis infections. In particular, an antiviral compound can be disposed within the lipid-coated particle, thereby providing an antiviral carrier. Methods of making and using such carriers are described herein.

Lipid-coated particles for treating viral infections

Growing community of inventors

San Francisco, CA, United States of America

Torri Elise Rinker